Innoviva Inc
INVA17.880USD
-0.320-1.76%
交易中 （美东）报价延迟15分钟
1.13B总市值
29.15市盈率 TTM
关于 Innoviva Inc 公司
Innoviva, Inc. 是一家多元化控股公司，拥有一系列专利和其他医疗资产。该公司的专利组合包括与葛兰素集团有限公司 (GSK) 合作的呼吸系统资产，包括 RELVAR/BREO ELLIPTA（糠酸氟替卡松/维兰特罗，FF/VI）和 ANORO ELLIPTA（溴化乌美溴铵/维兰特罗，UMEC/VI）。根据长效β2激动剂 (LABA) 合作协议，该公司有权从 GSK 获得 RELVAR/BREO、ELLIPTA 销售的专利使用费。该公司的产品包括 GIAPREZA（血管紧张素 II），获批用于增加感染性或其他分布性休克成人患者的血压，以及 XERAVA（埃拉环素），获批用于治疗成人复杂的腹腔内感染。第三款产品 XACDURO（以前称为舒巴坦-杜洛巴坦或 SUL-DUR）获批用于治疗成人不动杆菌引起的医院内获得性和呼吸机相关性肺炎。开发产品线包括佐利氟达星，这是一种用于治疗单纯性淋病的试验性药物，目前处于 III 期临床试验阶段。
Innoviva Inc简介
公司代码INVA
公司名称Innoviva Inc
上市日期Oct 05, 2004
CEOMr. Pavel Raifeld
员工数量127
证券类型Ordinary Share
年结日Oct 05
公司地址1350 Old Bayshore Highway
城市BURLINGAME
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编94010
电话16502389600
网址https://www.inva.com/
公司代码INVA
上市日期Oct 05, 2004
CEOMr. Pavel Raifeld
Innoviva Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Mark A. Dipaolo, Esq.
Mr. Mark A. Dipaolo, Esq.
Chairman of the Board
Chairman of the Board
130.71K
+10.18%
Dr. Sarah J. Schlesinger, M.D.
Dr. Sarah J. Schlesinger, M.D.
Lead Independent Director
Lead Independent Director
130.71K
+10.18%
Dr. Sapna Srivastava, Ph.D.
Dr. Sapna Srivastava, Ph.D.
Independent Director
Independent Director
44.10K
+11.98%
Ms. Marianne Y. Zhen, CPA
Ms. Marianne Y. Zhen, CPA
Chief Accounting Officer
Chief Accounting Officer
26.72K
-3.58%
Mr. Pavel Raifeld
Mr. Pavel Raifeld
Chief Executive Officer
Chief Executive Officer
12.60K
+8.03%
Mr. Stephen Basso
Mr. Stephen Basso
Chief Financial Officer
Chief Financial Officer
4.40K
-5.12%
Mr. Jules A. Haimovitz
Mr. Jules A. Haimovitz
Independent Director
Independent Director
--
--
Dr. Odysseas D. Kostas, M.D.
Dr. Odysseas D. Kostas, M.D.
Director
Director
--
--
Mr. Derek A Small
Mr. Derek A Small
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Mark A. Dipaolo, Esq.
Mr. Mark A. Dipaolo, Esq.
Chairman of the Board
Chairman of the Board
130.71K
+10.18%
Dr. Sarah J. Schlesinger, M.D.
Dr. Sarah J. Schlesinger, M.D.
Lead Independent Director
Lead Independent Director
130.71K
+10.18%
Dr. Sapna Srivastava, Ph.D.
Dr. Sapna Srivastava, Ph.D.
Independent Director
Independent Director
44.10K
+11.98%
Ms. Marianne Y. Zhen, CPA
Ms. Marianne Y. Zhen, CPA
Chief Accounting Officer
Chief Accounting Officer
26.72K
-3.58%
Mr. Pavel Raifeld
Mr. Pavel Raifeld
Chief Executive Officer
Chief Executive Officer
12.60K
+8.03%
Mr. Stephen Basso
Mr. Stephen Basso
Chief Financial Officer
Chief Financial Officer
4.40K
-5.12%
收入明细
FY2025Q2
FY2025Q1
FY2024
暂无数据
地区USD
名称
营收
占比
United States
100.28M
0.00%
业务
地区
暂无数据
股东统计
更新时间: 8月23日 周六
更新时间: 8月23日 周六
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
12.84%
The Vanguard Group, Inc.
11.36%
Renaissance Technologies LLC
7.55%
Dimensional Fund Advisors, L.P.
6.81%
Sarissa Capital Management, L.P.
4.47%
其他
56.96%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
12.84%
The Vanguard Group, Inc.
11.36%
Renaissance Technologies LLC
7.55%
Dimensional Fund Advisors, L.P.
6.81%
Sarissa Capital Management, L.P.
4.47%
其他
56.96%
股东类型
持股股东
占比
Investment Advisor
48.21%
Investment Advisor/Hedge Fund
36.84%
Hedge Fund
22.82%
Research Firm
6.85%
Bank and Trust
3.92%
Pension Fund
1.82%
Individual Investor
1.05%
Sovereign Wealth Fund
0.18%
Family Office
0.04%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
504
76.05M
120.67%
-969.78K
2025Q2
497
69.38M
110.09%
-7.80M
2025Q1
503
69.52M
110.75%
-9.29M
2024Q4
492
73.18M
116.75%
-6.44M
2024Q3
487
75.41M
120.47%
-5.51M
2024Q2
492
75.89M
121.41%
-5.03M
2024Q1
502
75.85M
119.80%
-4.18M
2023Q4
494
74.97M
116.88%
-1.82M
2023Q3
486
71.34M
109.51%
-8.23M
2023Q2
482
72.90M
111.23%
-6.11M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
8.09M
12.84%
-148.59K
-1.80%
Jun 30, 2025
The Vanguard Group, Inc.
7.16M
11.36%
+879.54K
+14.00%
Jun 30, 2025
Renaissance Technologies LLC
4.76M
7.55%
--
--
Jun 30, 2025
Dimensional Fund Advisors, L.P.
4.29M
6.81%
-365.40K
-7.84%
Jun 30, 2025
Sarissa Capital Management, L.P.
2.82M
4.47%
--
--
Jun 30, 2025
Putnam Investment Management, L.L.C.
2.75M
4.37%
-1.14M
-29.37%
Jun 30, 2025
State Street Investment Management (US)
2.46M
3.9%
+93.69K
+3.96%
Jun 30, 2025
Bank of Nova Scotia
3.59M
5.69%
-4.06M
-53.09%
Aug 29, 2025
American Century Investment Management, Inc.
2.07M
3.28%
+391.06K
+23.34%
Jun 30, 2025
Systematic Financial Management, L.P.
2.06M
3.27%
-12.08K
-0.58%
Jun 30, 2025
查看更多
持股ETF
更新时间: 11月2日 周日
更新时间: 11月2日 周日
机构名称
占比
Invesco Pharmaceuticals ETF
2.48%
First Trust Horizon Managed Vol Small/Mid ETF
2.11%
SPDR S&P Pharmaceuticals ETF
2.1%
ETC 6 Meridian Small Cap Equity ETF
1.98%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.58%
Vanguard US Minimum Volatility ETF
1.39%
Invesco S&P SmallCap Low Volatility ETF
1.12%
Pacer US Small Cap Cash Cows Growth Leaders ETF
1.02%
Acquirers Small and Micro Deep Value ETF
0.91%
Invesco S&P SmallCap Health Care ETF
0.69%
查看更多
Invesco Pharmaceuticals ETF
占比2.48%
First Trust Horizon Managed Vol Small/Mid ETF
占比2.11%
SPDR S&P Pharmaceuticals ETF
占比2.1%
ETC 6 Meridian Small Cap Equity ETF
占比1.98%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
占比1.58%
Vanguard US Minimum Volatility ETF
占比1.39%
Invesco S&P SmallCap Low Volatility ETF
占比1.12%
Pacer US Small Cap Cash Cows Growth Leaders ETF
占比1.02%
Acquirers Small and Micro Deep Value ETF
占比0.91%
Invesco S&P SmallCap Health Care ETF
占比0.69%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
